Alignment Healthcare, Inc. Common Stock ALHC
$13.46
-3.58%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $22.00
- Implied Upside
- +63.4%
- Price Target Range
- $16.00 – $30.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-04 | JP MorganJohn Stansel |
Maintains | Overweight | $26 → $22 |
| 2026-08-03 | Raymond JamesJohn Ransom |
Downgrades | Strong buy → Outperform | $22 → $19 |
| 2026-05-26 | BarclaysAndrew Mok |
Maintains | Equal-weight | $19 → $16 |
| 2026-05-01 | UBSJonathan Yong |
Maintains | Neutral | $21 → $22 |
| 2026-05-01 | BarclaysAndrew Mok |
Maintains | Equal-weight | $18 → $19 |
| 2026-02-05 | JP MorganJohn Stansel |
Maintains | Overweight | $23 → $26 |
| 2026-01-16 | TD CowenRyan Langston |
Maintains | Buy | $19 → $25 |
| 2026-01-14 | UBSKevin Caliendo |
Maintains | Neutral | $18 → $21 |
| 2026-01-06 | Piper SandlerJessica Tassan |
Maintains | Overweight | $20 → $30 |
| 2025-12-17 | JP MorganLisa Gill |
Maintains | Overweight | $20 → $23 |
| 2025-11-24 | JP MorganJohn Stansel |
Upgrades | Neutral → Overweight | $18 → $20 |
| 2025-11-05 | JP MorganLisa Gill |
Maintains | Neutral | $17 → $18 |
| 2025-11-03 | BarclaysAndrew Mok |
Maintains | Equal-weight | $13 → $18 |
| 2025-10-31 | UBSKevin Caliendo |
Maintains | Neutral | $17 → $18 |
| 2025-10-14 | Goldman SachsScott Fidel |
Initiates coverage on | Buy | $21 |
| 2025-08-25 | KeybancMatthew Gillmor |
Upgrades | Sector weight → Overweight | $21 |
| 2025-05-02 | UBSKevin Caliendo |
Maintains | Neutral | $16 → $17 |
| 2025-04-15 | BairdMichael Ha |
Maintains | Outperform | $17 → $22 |
| 2025-04-08 | StifelCraig Jones |
Maintains | Buy | $18 → $23 |
| 2025-03-06 | JP MorganLisa Gill |
Maintains | Neutral | $14 → $17 |
| 2025-03-04 | Piper SandlerJessica Tassan |
Maintains | Overweight | $14 → $21 |
| 2025-03-04 | B of A SecuritiesAdam Ron |
Maintains | Buy | $16 → $19 |
| 2025-02-28 | StifelCraig Jones |
Maintains | Buy | $16 → $18 |
| 2025-02-28 | BarclaysAndrew Mok |
Maintains | Underweight | $8 → $9 |
| 2025-02-24 | Stephens & Co.Raj Kumar |
Reiterates | Overweight | $17 |
| 2025-01-14 | StifelCraig Jones |
Maintains | Buy | $14 → $16 |
| 2025-01-02 | Stephens & Co.Scott Fidel |
Reiterates | Overweight | $17 |
| 2024-12-03 | Stephens & Co.Scott Fidel |
Upgrades | Equal-weight → Overweight | $13 → $17 |
| 2024-10-31 | TD CowenGary Taylor |
Maintains | Buy | $10 → $13 |
| 2024-10-30 | BarclaysAndrew Mok |
Maintains | Underweight | $7 → $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $13.46
- Market Cap
- $2.90 billion
- 52-Week Range
- $11.63 – $25.12
- Average Volume
- 5.63 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.